GITNUXREPORT 2026

Opioid Epidemic Statistics

Fentanyl drives a devastating opioid crisis with soaring overdose deaths across America.

Alexander Schmidt

Alexander Schmidt

Research Analyst specializing in technology and digital transformation trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

Opioids involved in 49% of ED visits for misuse 2019.

Statistic 2

Adults aged 35-44 had highest opioid overdose ED visit rate: 40.2 per 100,000 in 2021.

Statistic 3

Non-Hispanic Black persons: opioid death rate 31.5 per 100,000 in 2021.

Statistic 4

Rural residents 25% more likely to overdose than urban.

Statistic 5

Males accounted for 69% of opioid overdose deaths in 2021.

Statistic 6

American Indian/Alaska Native: highest opioid hospitalization rate 2018-2021.

Statistic 7

Ages 25-44: 56% of opioid deaths in 2021.

Statistic 8

Women: opioid misuse rate 0.9% vs men 1.1% in 2021.

Statistic 9

Appalachia: 32% of population but 20% of opioid deaths 2011-2015.

Statistic 10

Hispanic opioid death rate: 17.6 per 100,000 in 2021.

Statistic 11

Veterans: 20.7 opioid deaths per 100,000 in 2020.

Statistic 12

Pregnant women opioid prescriptions: 7% in 2020.

Statistic 13

Non-rural areas saw 30% rise in opioid deaths among Black individuals 2015-2019.

Statistic 14

Ages 12-17: 2.4% misused opioids past year 2021.

Statistic 15

Native Hawaiian/Pacific Islander: overdose rate 30.3 per 100,000.

Statistic 16

Low-income (<$20k) households: 2x opioid misuse rate.

Statistic 17

Southern states: 40% of national opioid prescriptions but higher misuse.

Statistic 18

Males 25-34: peak overdose death rate 70+ per 100,000.

Statistic 19

Black females opioid deaths tripled 2012-2021.

Statistic 20

Adults 65+: stable 10 per 100,000 death rate.

Statistic 21

Urban opioid hospitalization rates 1.5x rural post-2019.

Statistic 22

Less educated (HS or less): 2.5x higher OUD risk.

Statistic 23

Midwestern states opioid deaths disproportionately white males.

Statistic 24

Youth 12-20: ED visits for opioids fell 60% 2016-2020.

Statistic 25

Disability-linked households: 3x overdose rate.

Statistic 26

Asian Americans lowest misuse at 0.4% in 2021.

Statistic 27

Construction workers: highest OUD prevalence 5-10%.

Statistic 28

Females 85+: highest female death rate per capita.

Statistic 29

Tribal lands: opioid deaths 4x national average.

Statistic 30

Uninsured: 2x ED visits for opioid overdose.

Statistic 31

Baby boomers (55-73): rising misuse from prescriptions.

Statistic 32

Black males 25-44: fastest rising death rate 2015-2021.

Statistic 33

Farmers/ag workers: 35% higher overdose risk.

Statistic 34

LGBTQ+ youth: 20% higher misuse rates.

Statistic 35

Divorced/widowed: 1.8x OUD odds.

Statistic 36

Northeast urban Black communities: 50% death increase 2019-2021.

Statistic 37

Ages 45-54 males: 40.1 death rate per 100,000.

Statistic 38

Medicaid enrollees: 25% of opioid deaths despite 15% population.

Statistic 39

Native-born citizens higher misuse than immigrants.

Statistic 40

Military personnel past service: 1.5x OUD risk.

Statistic 41

In 2022, opioid epidemic cost U.S. economy $1.02 trillion.

Statistic 42

Healthcare costs for opioid use disorder: $78.4 billion annually pre-2020.

Statistic 43

Lost productivity from opioid deaths: $504 billion 2015-2020.

Statistic 44

Criminal justice costs: $42 billion yearly from opioid misuse.

Statistic 45

From 2015-2019, opioid crisis cost states $70 billion in direct spending.

Statistic 46

Worker absenteeism due to opioids: 3.7 million lost workdays 2017.

Statistic 47

Opioid-related hospitalizations cost $15.7 billion in 2012.

Statistic 48

Neonatal abstinence syndrome treatment: $2.6 billion yearly.

Statistic 49

In 2017, total economic burden $1.02 trillion including 47,000 deaths.

Statistic 50

Family members lost $13.5 billion in household earnings 2019.

Statistic 51

Medicare opioid spending: $4.5 billion on misuse 2019.

Statistic 52

Employer costs for opioid-dependent workers: $11,000 extra per employee yearly.

Statistic 53

2020 opioid crisis added $100 billion to healthcare spending.

Statistic 54

Lost tax revenue from opioid deaths: $12.4 billion annually.

Statistic 55

Child welfare costs: $8.2 billion yearly from opioid-affected families.

Statistic 56

In WV, opioid costs 7.5% of state GDP in 2017.

Statistic 57

Emergency services for overdoses: $3.6 billion in 2018.

Statistic 58

Disability claims from OUD: 1 million+, costing $20 billion SSA.

Statistic 59

Opioid makers settled lawsuits for $50+ billion 2019-2023.

Statistic 60

Reduced labor force participation: 1.1 million workers sidelined 2019.

Statistic 61

Treatment costs: $35 billion annually for OUD services.

Statistic 62

In 2021, opioid-related productivity losses $665 billion.

Statistic 63

Foster care placements doubled to 300,000 due to opioids, costing $10B.

Statistic 64

Hospitals wrote off $1.2 billion uncompensated opioid care 2017.

Statistic 65

Small businesses lost $15 billion in revenue from employee OUD 2018.

Statistic 66

Global opioid economic cost: $1 trillion yearly including U.S.

Statistic 67

Insurance premiums rose 7% due to opioid claims 2015-2020.

Statistic 68

Public assistance for OUD families: $25 billion SNAP/Medicaid.

Statistic 69

Opioid tourism in Canada cost provinces $500 million healthcare.

Statistic 70

U.S. GDP reduction 0.8% attributable to opioids 2017.

Statistic 71

Suicide-related opioid costs: $10 billion yearly.

Statistic 72

Law enforcement seizures costs $2 billion annually.

Statistic 73

Education impacts: 1.5 million kids miss school yearly, $5B lost.

Statistic 74

In 2019, per-death economic cost $1.02 million.

Statistic 75

MAT treatment ROI: $36,000 saved per patient yearly.

Statistic 76

Homelessness linked to opioids costs $4 billion sheltering.

Statistic 77

Tourism decline in hard-hit areas: 10% revenue drop.

Statistic 78

2023 projected costs exceed $1.5 trillion with inflation.

Statistic 79

Only 1 in 5 with OUD received treatment in 2021.

Statistic 80

Buprenorphine prescriptions increased 128% from 2013-2022.

Statistic 81

Naloxone distribution saved 26,000 lives 1996-2014.

Statistic 82

Medications for OUD (MOUD) used by 23% of those in treatment 2021.

Statistic 83

SAMHSA treatment facilities for opioids: 17,000+ in 2022.

Statistic 84

Overdose deaths declined 20% in communities with high naloxone access.

Statistic 85

Methadone patients retained 70% at 6 months vs 40% non-medicated.

Statistic 86

PDMP implementation reduced opioid overdoses 10-15%.

Statistic 87

2.3 million received substance use treatment, 1.4M for opioids 2021.

Statistic 88

Fentanyl test strips detected 90% of cases in pilot programs.

Statistic 89

Syringe services programs prevented 10,000+ HIV cases.

Statistic 90

Buprenorphine waiver holders increased to 108,000 by 2023.

Statistic 91

48 states have good Samaritan laws protecting naloxone users.

Statistic 92

Residential treatment completion: 55% for opioid patients.

Statistic 93

Telehealth MAT visits surged 150% during pandemic.

Statistic 94

Xylazine-opioid mixes prompted new reversal agents trials.

Statistic 95

Harm reduction funding: $1.1 billion in 2022 ARP.

Statistic 96

Contingency management boosted abstinence 50% in trials.

Statistic 97

Pregnant women in MAT: 70% better birth outcomes.

Statistic 98

911 Good Samaritan laws in 35 states reduced overdose deaths 11%.

Statistic 99

Peer recovery coaching improved retention 40%.

Statistic 100

Vivitrol (naltrexone) use rose 20% post-approval expansions.

Statistic 101

Community-based naloxone: 1 dose reverses 80% overdoses if prompt.

Statistic 102

OTPs (opioid treatment programs) served 500,000 patients 2022.

Statistic 103

Criminal justice diversion programs retained 60% in treatment.

Statistic 104

Psychedelic-assisted therapy trials for OUD phase 2 success 70%.

Statistic 105

Medicaid expansion states saw 25% more OUD treatment access.

Statistic 106

Sober living homes: 60% abstinence at 1 year.

Statistic 107

CDC guideline adherence reduced high-risk prescribing 50%.

Statistic 108

Fentanyl vaccine in animal trials prevented 85% overdose.

Statistic 109

Integrated care models for OUD+MH: 75% retention.

Statistic 110

Rural MAT access improved 300% with hub-spoke models.

Statistic 111

Nalmefene as alternative reversal agent approved EU, trials U.S.

Statistic 112

In 2021, the U.S. recorded 80,411 opioid-involved overdose deaths, a 22% increase from 2020.

Statistic 113

Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021.

Statistic 114

Heroin-involved overdose deaths totaled 9,273 in 2021, down from previous years.

Statistic 115

Natural and semisynthetic opioids caused 15,492 deaths in 2021.

Statistic 116

Methadone was implicated in 5,520 overdose deaths in 2021.

Statistic 117

From 1999 to 2021, nearly 645,000 people died from an opioid-involved overdose in the U.S.

Statistic 118

Opioid-involved death rates rose from 6.5 per 100,000 in 1999 to 32.3 per 100,000 in 2021.

Statistic 119

In 2022 provisional data, opioid deaths reached 81,806.

Statistic 120

Age-adjusted opioid overdose death rate was highest among adults aged 35-44 at 52.3 per 100,000 in 2021.

Statistic 121

Males had an opioid death rate of 45.5 per 100,000 vs. 20.0 for females in 2021.

Statistic 122

West Virginia had the highest opioid death rate at 81.4 per 100,000 in 2021.

Statistic 123

In 2019, opioid overdoses killed 49,860 people, 70.8% of all drug overdose deaths.

Statistic 124

Fentanyl analogs contributed to over 36,000 deaths in 2021.

Statistic 125

Neonatal abstinence syndrome cases linked to opioids affected 7 per 1,000 hospital births in 2017.

Statistic 126

Opioid deaths increased 309% from 2010 to 2020.

Statistic 127

In 2020, 91,799 drug overdose deaths occurred, with 75% opioid-related.

Statistic 128

Black non-Hispanic persons saw opioid death rates rise 44% from 2019-2020.

Statistic 129

Provisional 2023 data shows 74,702 opioid deaths.

Statistic 130

From May 2020 to April 2021, opioid deaths surged 37.7%.

Statistic 131

In Appalachia, opioid mortality rate was 50.2 per 100,000 from 2011-2015.

Statistic 132

In 2021, 24,486 deaths involved both opioids and stimulants.

Statistic 133

Opioid death rate for American Indian/Alaska Native was 56.6 per 100,000 in 2021.

Statistic 134

From 2015-2019, synthetic opioid deaths increased 345%.

Statistic 135

In Canada, opioid toxicity deaths reached 7,550 in 2022.

Statistic 136

UK opioid-related deaths were 4,907 in 2022, mostly methadone.

Statistic 137

Australia recorded 2,200 opioid deaths in 2021.

Statistic 138

In 2017, U.S. opioid prescriptions peaked but deaths continued rising due to illicit fentanyl.

Statistic 139

Emergency department visits for opioid overdoses doubled from 2016-2021 in some regions.

Statistic 140

2021 saw 13,162 deaths from prescription opioid overdoses.

Statistic 141

Opioid mortality among pregnant women rose 4-fold from 2007-2016.

Statistic 142

In 2021, 14 states had opioid death rates over 40 per 100,000.

Statistic 143

In 2019, 50,042 Americans died from opioid overdoses.

Statistic 144

High-dose opioid prescribing linked to 1 in 5 overdose deaths.

Statistic 145

In 2020, opioids were involved in 68.5% of all overdose deaths.

Statistic 146

From 1999-2020, opioid deaths totaled 500,000+.

Statistic 147

In 2022, fentanyl was in 68% of overdose deaths per toxicology.

Statistic 148

U.S. opioid death rate 3x higher than EU average in 2019.

Statistic 149

In 2018, 46,802 opioid deaths occurred.

Statistic 150

Rural opioid death rates 50% higher than urban in 2017.

Statistic 151

2021 cocaine-opioid deaths: 24,486.

Statistic 152

Opioid deaths in youth (15-24) rose 94% from 1999-2008.

Statistic 153

In 2021, the average annual opioid death rate increase was 14% over prior decade.

Statistic 154

New Mexico opioid death rate: 48.0 per 100,000 in 2021.

Statistic 155

In 2016, 42,249 opioid deaths marked record high then.

Statistic 156

Fentanyl death rate: 23.8 per 100,000 in 2021.

Statistic 157

Opioid deaths fell 8.6% in late 2023 provisional data.

Statistic 158

In 2020, 93,000+ total overdose deaths, 75% opioids.

Statistic 159

Black opioid death rate surpassed white in 2020 at 28.4 per 100,000.

Statistic 160

In 2015, prescription opioid deaths peaked at 15,691.

Statistic 161

Heroin deaths peaked at 15,469 in 2016.

Statistic 162

In Q1 2023, opioid deaths declined 13% from prior year.

Statistic 163

U.S. prescribers wrote 191.5 opioid prescriptions per 100 people in 2017.

Statistic 164

Opioid prescribing rates declined 44% from 2011 peak to 2020.

Statistic 165

In 2022, 41.9 million people aged 12+ misused prescription opioids.

Statistic 166

From 2006-2012, opioid prescriptions tripled to 259 million.

Statistic 167

High-dose opioid prescriptions (>90 MME) dropped 62% from 2010-2019.

Statistic 168

In 2012, enough opioids prescribed for every American to have 5-week supply.

Statistic 169

Opioid prescribing rate: 42.0 per 100 in 2021, down from 78.5 in 2012.

Statistic 170

Oxycodone prescriptions: 34 million in 2022.

Statistic 171

Hydrocodone prescriptions declined 57% from 2013-2020.

Statistic 172

In 2020, 9.3% of adults filled opioid prescription.

Statistic 173

Medicare Part D opioid prescriptions: 145 million in 2021.

Statistic 174

From 2013-2018, opioid dispensing rates fell 35.5%.

Statistic 175

In Appalachia, prescribing rates 50% higher than national average in 2017.

Statistic 176

12.5 million Americans misused prescription opioids in 2021.

Statistic 177

Opioid prescriptions per capita highest in Alabama: 101.7 in 2015.

Statistic 178

Post-2010 CDC guidelines, prescribing dropped 51% by 2020.

Statistic 179

In 2019, 10.1 million misused prescription pain relievers.

Statistic 180

Long-acting opioid prescriptions fell 79% from 2010-2020.

Statistic 181

Veteran opioid prescribing: 25% reduction 2012-2020.

Statistic 182

In 2022, 2.7% of U.S. population had opioid use disorder.

Statistic 183

Opioid sales quadrupled 1999-2010 to 219,000 lbs morphine equivalents.

Statistic 184

Pediatric opioid prescriptions declined 50% 2012-2021.

Statistic 185

Cancer patients opioid prescribing stable at 20-30% higher than non-cancer.

Statistic 186

In 2017, 18.0% of surgical patients received opioid prescription post-op.

Statistic 187

Telehealth opioid prescriptions surged 52% during COVID-19.

Statistic 188

Rural prescribing rates 23% higher than urban in 2019.

Statistic 189

Immediate-release opioids 80% of prescriptions but 30% of overdose deaths.

Statistic 190

From 2007-2017, opioid prescriptions to adolescents fell 40%.

Statistic 191

In 2021, average opioid prescription duration: 8.8 days.

Statistic 192

Opioid naive patients: 70% of new prescriptions under 3 days.

Statistic 193

States with PDMPs saw 10-25% drop in opioid volume post-implementation.

Statistic 194

In 2020, 16.6 million opioid prescriptions in emergency departments.

Statistic 195

Dentists prescribed 8% of opioids in 2016, down 30% since 2012.

Statistic 196

Opioid prescribing for chronic pain fell to 12% of visits by 2020.

Statistic 197

In 2021, White non-Hispanics had highest prescription rates at 10.4%.

Statistic 198

Opioid dispensing to ages 65+: 12.4% in 2020.

Statistic 199

In 2019, 2.0 million adolescents misused prescription opioids.

Statistic 200

High prescribing states like WV: 81.4 scripts per 100 in 2015.

Statistic 201

Post-surgery opioid fills: 80% within 7 days, 2012-2017.

Statistic 202

In 2022, buprenorphine prescriptions rose 22% to treat OUD.

Statistic 203

Opioid prescriptions in Medicaid: 15% of enrollees in 2021.

Statistic 204

From 2012-2021, opioid Rx per capita halved in most states.

Statistic 205

In 2021, 17.1% of U.S. adults experienced pain most days, many prescribed opioids.

Statistic 206

Emergency opioid prescriptions declined 29% 2012-2017.

Statistic 207

In 2020, 5.6 million adults misused prescription pain relievers.

Statistic 208

Rural Medicare opioid Rx rate: 8.8% vs urban 7.1% in 2019.

Statistic 209

Ages 25-44 had highest misuse rates at 1.4% in 2021.

Statistic 210

In 2016, 11.5 million misused prescription opioids past year.

Statistic 211

Opioid prescribing guidelines reduced doses by 60% in VA system.

Statistic 212

In 2022, 7.5% of pregnant women filled opioid prescriptions.

Statistic 213

Non-Hispanic White adults: 8.5% opioid prescription rate in 2020.

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Behind the staggering statistic that over 80,000 lives were lost to opioid overdoses in 2021 lies a deepening national crisis that demands our urgent attention and a comprehensive understanding of its evolving roots and devastating impact.

Key Takeaways

  • In 2021, the U.S. recorded 80,411 opioid-involved overdose deaths, a 22% increase from 2020.
  • Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021.
  • Heroin-involved overdose deaths totaled 9,273 in 2021, down from previous years.
  • U.S. prescribers wrote 191.5 opioid prescriptions per 100 people in 2017.
  • Opioid prescribing rates declined 44% from 2011 peak to 2020.
  • In 2022, 41.9 million people aged 12+ misused prescription opioids.
  • Opioids involved in 49% of ED visits for misuse 2019.
  • Adults aged 35-44 had highest opioid overdose ED visit rate: 40.2 per 100,000 in 2021.
  • Non-Hispanic Black persons: opioid death rate 31.5 per 100,000 in 2021.
  • In 2022, opioid epidemic cost U.S. economy $1.02 trillion.
  • Healthcare costs for opioid use disorder: $78.4 billion annually pre-2020.
  • Lost productivity from opioid deaths: $504 billion 2015-2020.
  • Only 1 in 5 with OUD received treatment in 2021.
  • Buprenorphine prescriptions increased 128% from 2013-2022.
  • Naloxone distribution saved 26,000 lives 1996-2014.

Fentanyl drives a devastating opioid crisis with soaring overdose deaths across America.

Demographic Impacts

  • Opioids involved in 49% of ED visits for misuse 2019.
  • Adults aged 35-44 had highest opioid overdose ED visit rate: 40.2 per 100,000 in 2021.
  • Non-Hispanic Black persons: opioid death rate 31.5 per 100,000 in 2021.
  • Rural residents 25% more likely to overdose than urban.
  • Males accounted for 69% of opioid overdose deaths in 2021.
  • American Indian/Alaska Native: highest opioid hospitalization rate 2018-2021.
  • Ages 25-44: 56% of opioid deaths in 2021.
  • Women: opioid misuse rate 0.9% vs men 1.1% in 2021.
  • Appalachia: 32% of population but 20% of opioid deaths 2011-2015.
  • Hispanic opioid death rate: 17.6 per 100,000 in 2021.
  • Veterans: 20.7 opioid deaths per 100,000 in 2020.
  • Pregnant women opioid prescriptions: 7% in 2020.
  • Non-rural areas saw 30% rise in opioid deaths among Black individuals 2015-2019.
  • Ages 12-17: 2.4% misused opioids past year 2021.
  • Native Hawaiian/Pacific Islander: overdose rate 30.3 per 100,000.
  • Low-income (<$20k) households: 2x opioid misuse rate.
  • Southern states: 40% of national opioid prescriptions but higher misuse.
  • Males 25-34: peak overdose death rate 70+ per 100,000.
  • Black females opioid deaths tripled 2012-2021.
  • Adults 65+: stable 10 per 100,000 death rate.
  • Urban opioid hospitalization rates 1.5x rural post-2019.
  • Less educated (HS or less): 2.5x higher OUD risk.
  • Midwestern states opioid deaths disproportionately white males.
  • Youth 12-20: ED visits for opioids fell 60% 2016-2020.
  • Disability-linked households: 3x overdose rate.
  • Asian Americans lowest misuse at 0.4% in 2021.
  • Construction workers: highest OUD prevalence 5-10%.
  • Females 85+: highest female death rate per capita.
  • Tribal lands: opioid deaths 4x national average.
  • Uninsured: 2x ED visits for opioid overdose.
  • Baby boomers (55-73): rising misuse from prescriptions.
  • Black males 25-44: fastest rising death rate 2015-2021.
  • Farmers/ag workers: 35% higher overdose risk.
  • LGBTQ+ youth: 20% higher misuse rates.
  • Divorced/widowed: 1.8x OUD odds.
  • Northeast urban Black communities: 50% death increase 2019-2021.
  • Ages 45-54 males: 40.1 death rate per 100,000.
  • Medicaid enrollees: 25% of opioid deaths despite 15% population.
  • Native-born citizens higher misuse than immigrants.
  • Military personnel past service: 1.5x OUD risk.

Demographic Impacts Interpretation

The opioid epidemic reveals itself not as a single tragedy but as a thousand distinct crises, where your risk of being consumed is determined by your age, your race, your job, your address, and your gender, with the most profound suffering often falling upon the communities America has already promised to forget.

Economic Burden

  • In 2022, opioid epidemic cost U.S. economy $1.02 trillion.
  • Healthcare costs for opioid use disorder: $78.4 billion annually pre-2020.
  • Lost productivity from opioid deaths: $504 billion 2015-2020.
  • Criminal justice costs: $42 billion yearly from opioid misuse.
  • From 2015-2019, opioid crisis cost states $70 billion in direct spending.
  • Worker absenteeism due to opioids: 3.7 million lost workdays 2017.
  • Opioid-related hospitalizations cost $15.7 billion in 2012.
  • Neonatal abstinence syndrome treatment: $2.6 billion yearly.
  • In 2017, total economic burden $1.02 trillion including 47,000 deaths.
  • Family members lost $13.5 billion in household earnings 2019.
  • Medicare opioid spending: $4.5 billion on misuse 2019.
  • Employer costs for opioid-dependent workers: $11,000 extra per employee yearly.
  • 2020 opioid crisis added $100 billion to healthcare spending.
  • Lost tax revenue from opioid deaths: $12.4 billion annually.
  • Child welfare costs: $8.2 billion yearly from opioid-affected families.
  • In WV, opioid costs 7.5% of state GDP in 2017.
  • Emergency services for overdoses: $3.6 billion in 2018.
  • Disability claims from OUD: 1 million+, costing $20 billion SSA.
  • Opioid makers settled lawsuits for $50+ billion 2019-2023.
  • Reduced labor force participation: 1.1 million workers sidelined 2019.
  • Treatment costs: $35 billion annually for OUD services.
  • In 2021, opioid-related productivity losses $665 billion.
  • Foster care placements doubled to 300,000 due to opioids, costing $10B.
  • Hospitals wrote off $1.2 billion uncompensated opioid care 2017.
  • Small businesses lost $15 billion in revenue from employee OUD 2018.
  • Global opioid economic cost: $1 trillion yearly including U.S.
  • Insurance premiums rose 7% due to opioid claims 2015-2020.
  • Public assistance for OUD families: $25 billion SNAP/Medicaid.
  • Opioid tourism in Canada cost provinces $500 million healthcare.
  • U.S. GDP reduction 0.8% attributable to opioids 2017.
  • Suicide-related opioid costs: $10 billion yearly.
  • Law enforcement seizures costs $2 billion annually.
  • Education impacts: 1.5 million kids miss school yearly, $5B lost.
  • In 2019, per-death economic cost $1.02 million.
  • MAT treatment ROI: $36,000 saved per patient yearly.
  • Homelessness linked to opioids costs $4 billion sheltering.
  • Tourism decline in hard-hit areas: 10% revenue drop.
  • 2023 projected costs exceed $1.5 trillion with inflation.

Economic Burden Interpretation

We have allowed a public health crisis to metastasize into a trillion-dollar tumor, hemorrhaging productivity from our workforce, stripping families of their livelihoods, and siphoning the lifeblood of our communities into a vortex of healthcare costs, criminal justice burdens, and incalculable human loss.

Intervention and Treatment

  • Only 1 in 5 with OUD received treatment in 2021.
  • Buprenorphine prescriptions increased 128% from 2013-2022.
  • Naloxone distribution saved 26,000 lives 1996-2014.
  • Medications for OUD (MOUD) used by 23% of those in treatment 2021.
  • SAMHSA treatment facilities for opioids: 17,000+ in 2022.
  • Overdose deaths declined 20% in communities with high naloxone access.
  • Methadone patients retained 70% at 6 months vs 40% non-medicated.
  • PDMP implementation reduced opioid overdoses 10-15%.
  • 2.3 million received substance use treatment, 1.4M for opioids 2021.
  • Fentanyl test strips detected 90% of cases in pilot programs.
  • Syringe services programs prevented 10,000+ HIV cases.
  • Buprenorphine waiver holders increased to 108,000 by 2023.
  • 48 states have good Samaritan laws protecting naloxone users.
  • Residential treatment completion: 55% for opioid patients.
  • Telehealth MAT visits surged 150% during pandemic.
  • Xylazine-opioid mixes prompted new reversal agents trials.
  • Harm reduction funding: $1.1 billion in 2022 ARP.
  • Contingency management boosted abstinence 50% in trials.
  • Pregnant women in MAT: 70% better birth outcomes.
  • 911 Good Samaritan laws in 35 states reduced overdose deaths 11%.
  • Peer recovery coaching improved retention 40%.
  • Vivitrol (naltrexone) use rose 20% post-approval expansions.
  • Community-based naloxone: 1 dose reverses 80% overdoses if prompt.
  • OTPs (opioid treatment programs) served 500,000 patients 2022.
  • Criminal justice diversion programs retained 60% in treatment.
  • Psychedelic-assisted therapy trials for OUD phase 2 success 70%.
  • Medicaid expansion states saw 25% more OUD treatment access.
  • Sober living homes: 60% abstinence at 1 year.
  • CDC guideline adherence reduced high-risk prescribing 50%.
  • Fentanyl vaccine in animal trials prevented 85% overdose.
  • Integrated care models for OUD+MH: 75% retention.
  • Rural MAT access improved 300% with hub-spoke models.
  • Nalmefene as alternative reversal agent approved EU, trials U.S.

Intervention and Treatment Interpretation

The statistics paint a picture of a crisis where, despite having a growing arsenal of effective tools—from naloxone to buprenorphine—and seeing undeniable proof they save lives, we are still tragically failing to connect the majority of those suffering with the comprehensive care they desperately need.

Mortality Statistics

  • In 2021, the U.S. recorded 80,411 opioid-involved overdose deaths, a 22% increase from 2020.
  • Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021.
  • Heroin-involved overdose deaths totaled 9,273 in 2021, down from previous years.
  • Natural and semisynthetic opioids caused 15,492 deaths in 2021.
  • Methadone was implicated in 5,520 overdose deaths in 2021.
  • From 1999 to 2021, nearly 645,000 people died from an opioid-involved overdose in the U.S.
  • Opioid-involved death rates rose from 6.5 per 100,000 in 1999 to 32.3 per 100,000 in 2021.
  • In 2022 provisional data, opioid deaths reached 81,806.
  • Age-adjusted opioid overdose death rate was highest among adults aged 35-44 at 52.3 per 100,000 in 2021.
  • Males had an opioid death rate of 45.5 per 100,000 vs. 20.0 for females in 2021.
  • West Virginia had the highest opioid death rate at 81.4 per 100,000 in 2021.
  • In 2019, opioid overdoses killed 49,860 people, 70.8% of all drug overdose deaths.
  • Fentanyl analogs contributed to over 36,000 deaths in 2021.
  • Neonatal abstinence syndrome cases linked to opioids affected 7 per 1,000 hospital births in 2017.
  • Opioid deaths increased 309% from 2010 to 2020.
  • In 2020, 91,799 drug overdose deaths occurred, with 75% opioid-related.
  • Black non-Hispanic persons saw opioid death rates rise 44% from 2019-2020.
  • Provisional 2023 data shows 74,702 opioid deaths.
  • From May 2020 to April 2021, opioid deaths surged 37.7%.
  • In Appalachia, opioid mortality rate was 50.2 per 100,000 from 2011-2015.
  • In 2021, 24,486 deaths involved both opioids and stimulants.
  • Opioid death rate for American Indian/Alaska Native was 56.6 per 100,000 in 2021.
  • From 2015-2019, synthetic opioid deaths increased 345%.
  • In Canada, opioid toxicity deaths reached 7,550 in 2022.
  • UK opioid-related deaths were 4,907 in 2022, mostly methadone.
  • Australia recorded 2,200 opioid deaths in 2021.
  • In 2017, U.S. opioid prescriptions peaked but deaths continued rising due to illicit fentanyl.
  • Emergency department visits for opioid overdoses doubled from 2016-2021 in some regions.
  • 2021 saw 13,162 deaths from prescription opioid overdoses.
  • Opioid mortality among pregnant women rose 4-fold from 2007-2016.
  • In 2021, 14 states had opioid death rates over 40 per 100,000.
  • In 2019, 50,042 Americans died from opioid overdoses.
  • High-dose opioid prescribing linked to 1 in 5 overdose deaths.
  • In 2020, opioids were involved in 68.5% of all overdose deaths.
  • From 1999-2020, opioid deaths totaled 500,000+.
  • In 2022, fentanyl was in 68% of overdose deaths per toxicology.
  • U.S. opioid death rate 3x higher than EU average in 2019.
  • In 2018, 46,802 opioid deaths occurred.
  • Rural opioid death rates 50% higher than urban in 2017.
  • 2021 cocaine-opioid deaths: 24,486.
  • Opioid deaths in youth (15-24) rose 94% from 1999-2008.
  • In 2021, the average annual opioid death rate increase was 14% over prior decade.
  • New Mexico opioid death rate: 48.0 per 100,000 in 2021.
  • In 2016, 42,249 opioid deaths marked record high then.
  • Fentanyl death rate: 23.8 per 100,000 in 2021.
  • Opioid deaths fell 8.6% in late 2023 provisional data.
  • In 2020, 93,000+ total overdose deaths, 75% opioids.
  • Black opioid death rate surpassed white in 2020 at 28.4 per 100,000.
  • In 2015, prescription opioid deaths peaked at 15,691.
  • Heroin deaths peaked at 15,469 in 2016.
  • In Q1 2023, opioid deaths declined 13% from prior year.

Mortality Statistics Interpretation

The grim arithmetic of the opioid crisis shows a devastating pivot from street to synthetic, as fentanyl transforms a slow-burning epidemic into an accelerating, unrelenting, and merciless national emergency.

Prescription Rates

  • U.S. prescribers wrote 191.5 opioid prescriptions per 100 people in 2017.
  • Opioid prescribing rates declined 44% from 2011 peak to 2020.
  • In 2022, 41.9 million people aged 12+ misused prescription opioids.
  • From 2006-2012, opioid prescriptions tripled to 259 million.
  • High-dose opioid prescriptions (>90 MME) dropped 62% from 2010-2019.
  • In 2012, enough opioids prescribed for every American to have 5-week supply.
  • Opioid prescribing rate: 42.0 per 100 in 2021, down from 78.5 in 2012.
  • Oxycodone prescriptions: 34 million in 2022.
  • Hydrocodone prescriptions declined 57% from 2013-2020.
  • In 2020, 9.3% of adults filled opioid prescription.
  • Medicare Part D opioid prescriptions: 145 million in 2021.
  • From 2013-2018, opioid dispensing rates fell 35.5%.
  • In Appalachia, prescribing rates 50% higher than national average in 2017.
  • 12.5 million Americans misused prescription opioids in 2021.
  • Opioid prescriptions per capita highest in Alabama: 101.7 in 2015.
  • Post-2010 CDC guidelines, prescribing dropped 51% by 2020.
  • In 2019, 10.1 million misused prescription pain relievers.
  • Long-acting opioid prescriptions fell 79% from 2010-2020.
  • Veteran opioid prescribing: 25% reduction 2012-2020.
  • In 2022, 2.7% of U.S. population had opioid use disorder.
  • Opioid sales quadrupled 1999-2010 to 219,000 lbs morphine equivalents.
  • Pediatric opioid prescriptions declined 50% 2012-2021.
  • Cancer patients opioid prescribing stable at 20-30% higher than non-cancer.
  • In 2017, 18.0% of surgical patients received opioid prescription post-op.
  • Telehealth opioid prescriptions surged 52% during COVID-19.
  • Rural prescribing rates 23% higher than urban in 2019.
  • Immediate-release opioids 80% of prescriptions but 30% of overdose deaths.
  • From 2007-2017, opioid prescriptions to adolescents fell 40%.
  • In 2021, average opioid prescription duration: 8.8 days.
  • Opioid naive patients: 70% of new prescriptions under 3 days.
  • States with PDMPs saw 10-25% drop in opioid volume post-implementation.
  • In 2020, 16.6 million opioid prescriptions in emergency departments.
  • Dentists prescribed 8% of opioids in 2016, down 30% since 2012.
  • Opioid prescribing for chronic pain fell to 12% of visits by 2020.
  • In 2021, White non-Hispanics had highest prescription rates at 10.4%.
  • Opioid dispensing to ages 65+: 12.4% in 2020.
  • In 2019, 2.0 million adolescents misused prescription opioids.
  • High prescribing states like WV: 81.4 scripts per 100 in 2015.
  • Post-surgery opioid fills: 80% within 7 days, 2012-2017.
  • In 2022, buprenorphine prescriptions rose 22% to treat OUD.
  • Opioid prescriptions in Medicaid: 15% of enrollees in 2021.
  • From 2012-2021, opioid Rx per capita halved in most states.
  • In 2021, 17.1% of U.S. adults experienced pain most days, many prescribed opioids.
  • Emergency opioid prescriptions declined 29% 2012-2017.
  • In 2020, 5.6 million adults misused prescription pain relievers.
  • Rural Medicare opioid Rx rate: 8.8% vs urban 7.1% in 2019.
  • Ages 25-44 had highest misuse rates at 1.4% in 2021.
  • In 2016, 11.5 million misused prescription opioids past year.
  • Opioid prescribing guidelines reduced doses by 60% in VA system.
  • In 2022, 7.5% of pregnant women filled opioid prescriptions.
  • Non-Hispanic White adults: 8.5% opioid prescription rate in 2020.

Prescription Rates Interpretation

The U.S. wrote itself into an addiction crisis by handing out opioids like party favors, only to spend the next decade frantically trying to collect them back, proving it's far easier to flood a nation with pills than to drain the misery they leave behind.